Chemically modified cystathionine beta-synthase enzyme for treatment of homocystinuria

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9034318
SERIAL NO

13803804

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention provides reagents and methods for enzyme replacement therapy using chemically modified species of human cystathionine β-synthase (CBS) to treat homocystinuria and other related diseases and disorders.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bublil, Erez Ets Efraim, IL 15 70
Kraus, Jan P Littleton, US 31 209
Majtan, Tomas Aurora, US 20 73

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Nov 19, 2026
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00